EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Wheat Allergy in the Era of Precision Medicine: From Novel Molecular Markers to New Therapeutic Perspectives

Solomiya Pukalyak iD, Weronika Gromek, Aleksandra Tomczak, Ewa Markut-Miotła, Maja Woźniak iD, Mariusz Wysokiński iD, Sylwia Smolinska iD, Emilia Majsiak iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Solomiya Pukalyak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Polish-Ukrainian Foundation for the Development of Medicine, Nałęczowska 14, 20-701 Lublin, Poland. Hauptthemen laut MEDLINE: Wheat Hypersensitivity, Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wheat allergy (WA) poses a diagnostic challenge due to its diverse clinical phenotypes—ranging from classic food allergy and wheat-dependent exercise-induced anaphylaxis (WDEIA) to baker’s asthma. An additional diagnostic aspect is serological cross-reactivity with grass pollen. Undoubtedly, the transition from extract-based diagnostics to precise component-based diagnostics (CRDs) facilitates the management of wheat allergy. It has significantly improved the diagnostic accuracy for WDEIA ω-5-gliadin (Tri a 19), although considering new knowledge about wheat proteins, it seems necessary to include them in the diagnostic scheme, especially where Tri a 19 remains negative despite clinical symptoms. Therefore, in this review, we evaluate the clinical utility of new wheat molecules with a high risk of anaphylaxis. We pay particular attention to Tri a 37 (α-purothionin), a thermally stable allergen associated with a 4-fold increase in the risk of severe anaphylaxis, and Tri a 36 (LMW glutenin), which shows higher sensitivity than Tri a 19 in specific pediatric cohorts. In addition, we emphasize the role of Tri a 14 (nsLTP) in distinguishing true wheat sensitization from pollen-related cross-reactivity caused by profilins (Tri a 12) or carbohydrate determinants (CCDs). Beyond diagnostics, the review discusses dynamic changes in sensitization profiles in relation to the allergic march and the phenomenon of spontaneous remission in children. New management strategies are also discussed, including the potential of omalizumab (based on the data from the OUtMATCH study) in facilitating the reintroduction of allergens into the diet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wheat HypersensitivityPrecision MedicineHumansBiomarkersAllergensAnaphylaxisTriticumAntigens, PlantGliadinCross ReactionsPollen

Stichwörter der Autor:innen

Tri a 36 (LMW glutenin)Tri a 37 (alpha-purothionin)anaphylaxiscomponent-resolved diagnostics (CRDs)omalizumabwheat allergy

Substanzen

BiomarkersAllergensAntigens, PlantGliadin

Autor:innen und Institutionen

  • Polish-Ukrainian Foundation for the Development of Medicine, Nałęczowska 14, 20-701 Lublin, Poland.
  • Independent Public Healthcare Centre of the Ministry of Internal Affairs and Administration in Lublin, Grenadierów 3, 20-331 Lublin, Poland.
  • Department of Allergology and Paediatry, Medical University of Lublin, Prof. Antoniego Gębali 6, 20-093 Lublin, Poland.
  • Department of Basic Nursing, Faculty of Health Sciences, Medical University of Lublin, Staszica 4/6, 20-081 Lublin, Poland.
  • Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland.
  • Health Promotion Department, Faculty of Health Sciences, Medical University of Lublin, Staszica 4/6, 20-081 Lublin, Poland.

ORCID-Profile: Solomiya Pukalyak, Maja Woźniak, Mariusz Wysokiński, Sylwia Smolinska, Emilia Majsiak

Zitieren

APA

Pukalyak, S., Gromek, W., Tomczak, A., Markut-Miotła, E., Woźniak, M., Wysokiński, M., Smolinska, S., & Majsiak, E. (2026). Wheat Allergy in the Era of Precision Medicine: From Novel Molecular Markers to New Therapeutic Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041717

Vancouver

Pukalyak S, Gromek W, Tomczak A, Markut-Miotła E, Woźniak M, Wysokiński M, et al. Wheat Allergy in the Era of Precision Medicine: From Novel Molecular Markers to New Therapeutic Perspectives. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041717

BibTeX
@article{Pukalyak2026,
  author = {Pukalyak, Solomiya and Gromek, Weronika and Tomczak, Aleksandra and Markut-Miotła, Ewa and Woźniak, Maja and Wysokiński, Mariusz and Smolinska, Sylwia and Majsiak, Emilia},
  title = {Wheat Allergy in the Era of Precision Medicine: From Novel Molecular Markers to New Therapeutic Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041717}
}
Kostenlos starten →